Review article: definition and diagnosis in portal hypertension--continued problems with the Baveno consensus?

R de Franchis1

  • 1Gastroenterology and Gastrointestinal Endoscopy Service, Department of Internal Medicine, University of Milan, IRCCS Ospedale Policlinico, Italy. gastro@policlinico.mi.it

Insights

The Baveno workshops established consensus definitions and guidelines for portal hypertension and variceal bleeding clinical trials. A study found tachycardia, a bleeding control criterion, was misleading in 15% of patients.

Area of Science:

  • Gastroenterology
  • Clinical Trial Methodology
  • Hepatology

Background:

  • Portal hypertension and variceal bleeding necessitate standardized definitions and guidelines for clinical research.
  • Previous Baveno workshops aimed to establish consensus on key events and trial conduct.

Purpose of the Study:

  • To develop consensus definitions for portal hypertension and variceal bleeding events.
  • To create guidelines for conducting and reporting clinical trials in this field.
  • To evaluate the applicability of existing Baveno definitions.

Main Methods:

  • Consensus development through expert workshops.
  • Formulation of definitions for bleeding, rebleeding, and prophylaxis.
  • Evaluation of Baveno definitions in a clinical study setting.
  • Testing criteria such as tachycardia for failure to control bleeding.

Main Results:

  • Consensus definitions for active bleeding, bleeding control failure, rebleeding, and prophylaxis were established.
  • Guidelines were produced for diagnostic endoscopy, fluid resuscitation, infection prevention, and treatment.
  • The study evaluating Baveno definitions identified tachycardia as a misleading criterion in 15% of patients.

Conclusions:

  • The Baveno definitions and guidelines provide a framework for portal hypertension and variceal bleeding research.
  • Ongoing adaptation based on practical application is intended.
  • Refinement of diagnostic criteria, like tachycardia, is necessary for improved clinical trial accuracy.

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...